News & Announcements
The Sydney Addiction Seminars are a post-graduate health education series now held under the auspices of Drug Health Services, Royal Prince Alfred Hospital, and the Department of Addiction Medicine, University of Sydney. They are convened by Dr Richard Hallinan and Professor Paul Haber.
Wednesday 22nd June 2016
“Are we there yet?.” The first three months experience of the new Hepatitis C treatments.
On March 1 2016 directly acting antiviral medications for hepatitis C became available in Australia with Medicare Pharmaceutical Benefits Scheme subsidy, making them affordable and available without restrictions for the majority of people with hepatitis C genotypes 1, 2 and 3. These treatments are more effective and much more tolerable than interferon based treatments, and can be prescribed by GPs and other community prescribers with specialist support. The majority of people with chronic hepatitis C can be safely and effectively treated. How has that translated into clinical practice?
Paul Haber will lead a seminar focusing on who and how to treat with these medications, with reflections on the first 3 months experience of the new Hepatitis C treatments, and an emphasis on AOD settings.
Presenter: Professor Paul Haber, Clinical Director, Drug Health Services, Sydney Local Health District.
We aim to make these seminars as interactive as possible. Please email your suggestions to for cases and questions to Richard Hallinan at firstname.lastname@example.org
The Sydney Addiction Seminars will hosted again this year by Drug Health Services, RPAH, and held in the Scott Skirving Theatre from 7pm-9pm on Wednesday evenings as per the programme below.
There will be four seminars this year, presented by experts from four Local Health Districts. Participation will now also be possible by webinar for those who cannot attend in person.
Venue: Scott Skirving Theatre, RPAH, Camperdown
6.30pm for introductions and refreshments, sessions starts at 7pm. No booking necessary, but to assist with catering please RSVP interest to email@example.com or call Drug Health Services RPAH on 02 9515 6419
This seminar series attracts 2 points/hour for RACGP QA&CPD (activity number 715352).
The sessions and refreshments are again supported this year by Reckitt Benckiser, makers of buprenorphine and buprenorphine/naloxone